Literature DB >> 26927597

Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Brian G Southwell1, Douglas J Rupert1.   

Abstract

Despite increased availability of online promotional tools for prescription drug marketers, evidence on online prescription drug promotion is far from settled or conclusive. We highlight ways in which online prescription drug promotion is similar to conventional broadcast and print advertising and ways in which it differs. We also highlight five key areas for future research: branded drug website influence on consumer knowledge and behavior, interactive features on branded drug websites, mobile viewing of branded websites and mobile advertisements, online promotion and non-US audiences, and social media and medication decisions.
© 2016 by Kerman University of Medical Sciences.

Keywords:  Direct-to-Consumer (DTC) Advertising; Health Communication; Prescription Drug; Social Media

Mesh:

Substances:

Year:  2016        PMID: 26927597      PMCID: PMC4770931          DOI: 10.15171/ijhpm.2016.05

Source DB:  PubMed          Journal:  Int J Health Policy Manag        ISSN: 2322-5939


  18 in total

1.  Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.

Authors:  Hyosun Kim
Journal:  Int J Health Policy Manag       Date:  2015-08-25

2.  Is the information "fair and balanced" in direct-to-consumer prescription drug websites?

Authors:  Jisu Huh; Brenda J Cude
Journal:  J Health Commun       Date:  2004 Nov-Dec

3.  Health-related message boards/chat rooms on the Web: discussion content and implications for pharmaceutical sponsorships.

Authors:  Wendy Macias; Liza Stavchansky Lewis; Tenikka L Smith
Journal:  J Health Commun       Date:  2005 Apr-May

4.  Use of anonymous Web communities and websites by medical consumers in Japan to research drug information.

Authors:  Keiko Kishimoto; Noriko Fukushima
Journal:  Yakugaku Zasshi       Date:  2011       Impact factor: 0.302

5.  Low literacy impairs comprehension of prescription drug warning labels.

Authors:  Terry C Davis; Michael S Wolf; Pat F Bass; Mark Middlebrooks; Estela Kennen; David W Baker; Charles L Bennett; Ramon Durazo-Arvizu; Anna Bocchini; Stephanie Savory; Ruth M Parker
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

6.  Perceived healthcare provider reactions to patient and caregiver use of online health communities.

Authors:  Douglas J Rupert; Rebecca R Moultrie; Jennifer Gard Read; Jacqueline B Amoozegar; Alexandra S Bornkessel; Amie C O'Donoghue; Helen W Sullivan
Journal:  Patient Educ Couns       Date:  2014-05-29

7.  Literacy and misunderstanding prescription drug labels.

Authors:  Terry C Davis; Michael S Wolf; Pat F Bass; Jason A Thompson; Hugh H Tilson; Marolee Neuberger; Ruth M Parker
Journal:  Ann Intern Med       Date:  2006-11-29       Impact factor: 25.391

8.  Quantifying age-related differences in information processing behaviors when viewing prescription drug labels.

Authors:  Raghav Prashant Sundar; Mark W Becker; Nora M Bello; Laura Bix
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

9.  Prevalence and Global Health implications of social media in direct-to-consumer drug advertising.

Authors:  Bryan A Liang; Timothy K Mackey
Journal:  J Med Internet Res       Date:  2011-08-31       Impact factor: 5.428

10.  Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.

Authors:  Jennifer Tyrawski; David C DeAndrea
Journal:  J Med Internet Res       Date:  2015-06-01       Impact factor: 5.428

View more
  5 in total

1.  Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries.

Authors:  Hyosun Kim
Journal:  Int J Health Policy Manag       Date:  2016-10-01

2.  Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Douglas J Rupert; Jessica Fitts Willoughby; Kathryn J Aikin
Journal:  J Health Commun       Date:  2017-01-27

3.  Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Douglas J Rupert; Jessica Fitts Willoughby; Jacqueline B Amoozegar; Kathryn J Aikin
Journal:  J Health Commun       Date:  2016-11-02

4.  How Affiliation Disclosure and Control Over User-Generated Comments Affects Consumer Health Knowledge and Behavior: A Randomized Controlled Experiment of Pharmaceutical Direct-to-Consumer Advertising on Social Media.

Authors:  David Christopher DeAndrea; Megan Ashley Vendemia
Journal:  J Med Internet Res       Date:  2016-07-19       Impact factor: 5.428

5.  Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Jennifer Gard Read; Jacqueline B Amoozegar; Kathryn J Aikin; Douglas J Rupert
Journal:  J Med Internet Res       Date:  2018-01-23       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.